TROP-2-targeted antibody-drug conjugate SHR-A1921 for advanced or metastatic solid tumors: A first-in-human phase 1 study

作者：Jia Zhong, Lin Wu, Zhengbo Song, Nianzeng Xing, Jiujie Cui, Xingya Li, Kailun Fei, Dihong Tang, Qi Dang, Chen Liang, Tianshu Liu, Caigang Liu, Yong Li, Shichuan Zhang, Xinghua Han, Juxiang Xiao, Feng Guo, Min Yan, Huiting Xu, Chunxiu Yuan, Jincai Zhong, Rongrui Liu, Xiujuan Qu, Shikai Wu, Shusuan Jiang, Yan Yang, Panpan Zhang, Hongqian Guo, Ce Wang, Qiushi Xie, Zhifei Lin, Shuni Wang, Jie Wang · 发表于：Cancer Cell · 年份：2025 · DOI：10.1016/j.ccell.2025.09.012 · 被引用次数：10 · 研究领域：HER2/EGFR in Cancer Research、Lung Cancer Treatments and Mutations、PI3K/AKT/mTOR signaling in cancer